[ Price : $8.95]
FDA approves a Warner Chilcott NDA for Atelvia delayed-release tablets, described as its next generation of Actonel (risedronate ...[ Price : $8.95]
MedImmune begins a Phase 1 trial with MT111 in patients with advanced gastrointestinal cancers.[ Price : $8.95]
Harvard author of a potent new FDA book Daniel Carpenter draws parallels between the beleaguered agency that won historic regulato...[ Price : $8.95]
BioSante Pharmaceuticals says it is planning a 2011 NDA submission to FDA for its LibiGel testosterone treatment for female sexual...[ Price : $8.95]
FDA principal deputy commissioner Joshua Sharfstein says the agency can use pharmacy school help in learning how best to use the a...[ Price : $8.95]
FDA grants Stem Cell Therapeutics an end-of-Phase 2 meeting with FDA to review its NTx-265 clinical programs.[ Price : $8.95]
FDA says it is considering a communication to oncologists and other healthcare professionals on a newly discovered risk of toxic o...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on additional criteria for classifying OTC drugs as generally recognized as safe and e...